Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia.

Narula N, Dannenberg AJ, Olin JW, Bhatt DL, Johnson KW, Nadkarni G, Min J, Torii S, Poojary P, Anand SS, Bax JJ, Yusuf S, Virmani R, Narula J.

J Am Coll Cardiol. 2018 Oct 30;72(18):2152-2163. doi: 10.1016/j.jacc.2018.08.002. Epub 2018 Aug 27.

PMID:
30166084
2.

Impact of lesion location on procedural and acute angiographic outcomes in patients with critical limb ischemia treated for peripheral artery disease with orbital atherectomy: A CONFIRM registries subanalysis.

Lee MS, Mustapha J, Beasley R, Chopra P, Das T, Adams GL.

Catheter Cardiovasc Interv. 2016 Feb 15;87(3):440-5. doi: 10.1002/ccd.26349. Epub 2015 Dec 9.

PMID:
26649816
3.

Midterm Outcomes After Infrapopliteal Interventions in Patients With Critical Limb Ischemia Based on the TASC II Classification of Below-the-Knee Arteries.

Singh GD, Brinza EK, Hildebrand J, Waldo SW, Foley TR, Laird JR, Armstrong EJ.

J Endovasc Ther. 2017 Jun;24(3):321-330. doi: 10.1177/1526602817704643. Epub 2017 Apr 19.

PMID:
28421855
4.

Arteriographic Patterns of Atherosclerosis and the Association between Diabetes Mellitus and Ethnicity in Chronic Critical Limb Ischemia.

Chung J, Modrall JG, Knowles M, Xiang Q, Lavery LA, Timaran CH, Valentine RJ.

Ann Vasc Surg. 2017 Apr;40:198-205. doi: 10.1016/j.avsg.2016.11.003. Epub 2016 Nov 28.

PMID:
27908824
6.

Patterns of artery disease in 450 patients undergoing revascularization for critical limb ischemia: implications for clinical trial design.

Rueda CA, Nehler MR, Perry DJ, McLafferty RB, Casserly IP, Hiatt WR, Peyton BD.

J Vasc Surg. 2008 May;47(5):995-9; discussion 999-1000. doi: 10.1016/j.jvs.2007.11.055. Epub 2008 Apr 18.

7.

The impact of isolated tibial disease on outcomes in the critical limb ischemic population.

Gray BH, Grant AA, Kalbaugh CA, Blackhurst DW, Langan EM 3rd, Taylor SA, Cull DL.

Ann Vasc Surg. 2010 Apr;24(3):349-59. doi: 10.1016/j.avsg.2009.07.034. Epub 2010 Jan 4.

PMID:
20045628
8.

Everolimus-Eluting Stent for Patients With Critical Limb Ischemia and Infrapopliteal Arterial Occlusive Disease.

Giaquinta A, Vincenzo A, De Marco E, Veroux M, Veroux P.

Vasc Endovascular Surg. 2017 Feb;51(2):60-66. doi: 10.1177/1538574416689429. Epub 2017 Jan 18.

PMID:
28100126
9.

Lower extremity computed tomography angiography can help predict technical success of endovascular revascularization in the superficial femoral and popliteal artery.

Itoga NK, Kim T, Sailer AM, Fleischmann D, Mell MW.

J Vasc Surg. 2017 Sep;66(3):835-843.e1. doi: 10.1016/j.jvs.2017.02.031. Epub 2017 May 11.

10.

Single-Center Experience With Lutonix Drug-Coated Balloons in Infrapopliteal Arteries.

Steiner S, Schmidt A, Bausback Y, Bräunlich S, Ulrich M, Banning-Eichenseer U, Scheinert D.

J Endovasc Ther. 2016 Jun;23(3):417-23. doi: 10.1177/1526602816645080. Epub 2016 Apr 20.

PMID:
27099285
11.

Endovascular recanalization of infrapopliteal occlusions in patients with critical limb ischemia.

Singh GD, Armstrong EJ, Yeo KK, Singh S, Westin GG, Pevec WC, Dawson DL, Laird JR.

J Vasc Surg. 2014 May;59(5):1300-7. doi: 10.1016/j.jvs.2013.11.061. Epub 2014 Jan 3.

12.

Infrapopliteal calcification patterns in critical limb ischemia: diagnostic, pathologic and therapeutic implications in the search for the endovascular holy grail.

Mustapha JA, Diaz-Sandoval LJ, Saab F.

J Cardiovasc Surg (Torino). 2017 Jun;58(3):383-401. doi: 10.23736/S0021-9509.17.09878-0. Epub 2017 Feb 27. Review.

PMID:
28240525
13.

Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.

Shammas AN, Jeon-Slaughter H, Tsai S, Khalili H, Ali M, Xu H, Rodriguez G, Cawich I, Armstrong EJ, Brilakis ES, Banerjee S.

J Endovasc Ther. 2017 Jun;24(3):376-382. doi: 10.1177/1526602817705135. Epub 2017 Apr 25.

14.

[Endovascular treatment of below the knee arteries in critical limb ischemia].

Bonvini RF, Roffi M.

Rev Med Suisse. 2010 Jun 2;6(251):1146-8, 1150-3. French.

PMID:
20572359
15.

Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta-analysis of randomized trials.

Fusaro M, Cassese S, Ndrepepa G, Tepe G, King L, Ott I, Nerad M, Schunkert H, Kastrati A.

JACC Cardiovasc Interv. 2013 Dec;6(12):1284-93. doi: 10.1016/j.jcin.2013.08.007. Review.

16.
17.

A prospective analysis of critical limb ischemia: factors leading to major primary amputation versus revascularization.

Abou-Zamzam AM Jr, Gomez NR, Molkara A, Banta JE, Teruya TH, Killeen JD, Bianchi C.

Ann Vasc Surg. 2007 Jul;21(4):458-63. Epub 2007 May 17.

PMID:
17499967
18.

Histopathologic Characterization of Peripheral Arteries in Subjects With Abundant Risk Factors: Correlating Imaging With Pathology.

Torii S, Mustapha JA, Narula J, Mori H, Saab F, Jinnouchi H, Yahagi K, Sakamoto A, Romero ME, Narula N, Kolodgie FD, Virmani R, Finn AV.

JACC Cardiovasc Imaging. 2018 Dec 6. pii: S1936-878X(18)31008-8. doi: 10.1016/j.jcmg.2018.08.039. [Epub ahead of print]

PMID:
30553660
19.

Drug eluting stents for below the knee lesions in patients with critical limb ischemia : long-term follow-up.

Rosales OR, Mathewkutty S, Gnaim C.

Catheter Cardiovasc Interv. 2008 Jul 1;72(1):112-5. doi: 10.1002/ccd.21557.

PMID:
18412272
20.

IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial.

Zeller T, Baumgartner I, Scheinert D, Brodmann M, Bosiers M, Micari A, Peeters P, Vermassen F, Landini M; IN.PACT DEEP Trial Investigators.

Trials. 2014 Feb 19;15:63. doi: 10.1186/1745-6215-15-63.

Supplemental Content

Support Center